Company Filing History:
Years Active: 2018
Title: Brunhilde Wirth: Innovator in Neurocalcin Delta Inhibitors
Introduction
Brunhilde Wirth is a prominent inventor based in Bonn, Germany. She has made significant contributions to the field of neuroscience through her innovative research and patents. Her work focuses on neurocalcin delta inhibitors and their therapeutic applications.
Latest Patents
Brunhilde Wirth holds a patent for "Neurocalcin delta inhibitors and therapeutic and non-therapeutic uses thereof." This invention relates to an inhibitor of neurocalcin delta (NCALD) for use in treating or preventing disorders associated with pathological calcium homeostasis. The patent also discusses the use of NCALD inhibitors for inducing axon proliferation in vitro and methods for differentiating and maturing neuronal stem cells (NSCs). Additionally, it addresses the restoration of impaired endocytosis due to disturbed calcium homeostasis in synaptic terminals, which is essential for the development, maturation, and maintenance of synapses and neuromuscular junctions (NMJs).
Career Highlights
Brunhilde Wirth is affiliated with the University of Cologne, where she conducts her research. Her work has garnered attention for its potential impact on treating neurological disorders. She has a strong academic background and is dedicated to advancing the understanding of calcium homeostasis in neuronal function.
Collaborations
Brunhilde collaborates with Markus Riessland, enhancing the scope and depth of her research. Their partnership has led to significant advancements in the field of neuroscience.
Conclusion
Brunhilde Wirth is a trailblazer in the development of neurocalcin delta inhibitors, with a focus on their therapeutic applications. Her innovative work at the University of Cologne continues to contribute to the understanding of neurological disorders and potential treatments.